The University of Chicago Header Logo

Connection

Jon E. Grant to Narcotic Antagonists

This is a "connection" page, showing publications Jon E. Grant has written about Narcotic Antagonists.
Connection Strength

5.148
  1. Use of Anticraving Agents in the Treatment of Exhibitionism and Frotteuristic Disorder. J Clin Psychopharmacol. 2021 Sep-Oct 01; 41(5):611-612.
    View in: PubMed
    Score: 0.678
  2. The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2014 Feb; 34(1):134-8.
    View in: PubMed
    Score: 0.401
  3. Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry. 2010 Oct; 197(4):330-1.
    View in: PubMed
    Score: 0.318
  4. A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry. 2009 Apr 01; 65(7):600-6.
    View in: PubMed
    Score: 0.284
  5. Predicting response to opiate antagonists and placebo in the treatment of pathological gambling. Psychopharmacology (Berl). 2008 Nov; 200(4):521-7.
    View in: PubMed
    Score: 0.272
  6. A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges. J Clin Psychiatry. 2008 May; 69(5):783-9.
    View in: PubMed
    Score: 0.269
  7. Medication management of pathological gambling. Minn Med. 2006 Sep; 89(9):44-8.
    View in: PubMed
    Score: 0.240
  8. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry. 2006 Feb; 163(2):303-12.
    View in: PubMed
    Score: 0.230
  9. Understanding and treating kleptomania: new models and new treatments. Isr J Psychiatry Relat Sci. 2006; 43(2):81-7.
    View in: PubMed
    Score: 0.229
  10. Trait Impulsivity Predicts Treatment Response in Gambling Disorder. Clin Neuropharmacol. 2025 Mar-Apr 01; 48(2):27-28.
    View in: PubMed
    Score: 0.215
  11. Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade. Psychosom Med. 2004 Mar-Apr; 66(2):198-206.
    View in: PubMed
    Score: 0.202
  12. Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry. 2004 Jan-Mar; 16(1):27-34.
    View in: PubMed
    Score: 0.199
  13. An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry. 2002 Apr; 63(4):349-56.
    View in: PubMed
    Score: 0.177
  14. Adolescent kleptomania treated with naltrexone--a case report. Eur Child Adolesc Psychiatry. 2002 Apr; 11(2):92-5.
    View in: PubMed
    Score: 0.177
  15. A case of kleptomania and compulsive sexual behavior treated with naltrexone. Ann Clin Psychiatry. 2001 Dec; 13(4):229-31.
    View in: PubMed
    Score: 0.173
  16. The psychopharmacology of pathological gambling. Semin Clin Neuropsychiatry. 2001 Jul; 6(3):184-94.
    View in: PubMed
    Score: 0.168
  17. Cold pressor pain and gambling disorder: implications for the opioid system. CNS Spectr. 2020 06; 25(3):426-433.
    View in: PubMed
    Score: 0.145
  18. Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking. Alcohol Clin Exp Res. 2014 Oct; 38(10):2622-9.
    View in: PubMed
    Score: 0.105
  19. Compulsive buying treated with motivational interviewing and imaginal desensitization. Ann Clin Psychiatry. 2011 Aug; 23(3):226-7.
    View in: PubMed
    Score: 0.084
  20. Augmentation with naltrexone to treat compulsive sexual behavior: a case series. Ann Clin Psychiatry. 2010 Feb; 22(1):56-62.
    View in: PubMed
    Score: 0.076
  21. Pharmacological treatment of adolescent pathological gambling. Int J Adolesc Med Health. 2010 Jan-Mar; 22(1):129-38.
    View in: PubMed
    Score: 0.076
  22. Naltrexone effect on physiological and subjective response to a cold pressor task. Biol Psychol. 2008 Feb; 77(2):233-6.
    View in: PubMed
    Score: 0.065
  23. [Kleptomania: clinical characteristics and treatment]. Braz J Psychiatry. 2008 May; 30 Suppl 1:S11-5.
    View in: PubMed
    Score: 0.064
  24. Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome. Harv Rev Psychiatry. 2007 Mar-Apr; 15(2):80-5.
    View in: PubMed
    Score: 0.062
  25. Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients. Clin Neuropharmacol. 2006 Mar-Apr; 29(2):77-9.
    View in: PubMed
    Score: 0.058
  26. Pharmacological management of gambling disorder: A systematic review and network meta-analysis. Compr Psychiatry. 2025 Feb; 137:152566.
    View in: PubMed
    Score: 0.053
  27. Advances in the pharmacological treatment of pathological gambling. J Gambl Stud. 2003; 19(1):85-109.
    View in: PubMed
    Score: 0.047
  28. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001 Jun 01; 49(11):914-21.
    View in: PubMed
    Score: 0.042
  29. The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res. 2009 Mar 31; 166(1):76-84.
    View in: PubMed
    Score: 0.018
  30. Pathological gambling. Current status and new treatments. Minn Med. 2002 Jul; 85(7):48-50, 52.
    View in: PubMed
    Score: 0.011
  31. A preliminary report on possible naltrexone and nonsteroidal analgesic interactions. J Clin Psychopharmacol. 2001 Dec; 21(6):632-4.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.